Skip to content

Efficacy and Safety of Fermented Velvet Antler Extract on Fatigue Recovery After Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01689467
Enrollment
60
Registered
2012-09-21
Start date
2013-04-25
Completion date
2014-06-26
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Brief summary

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Velvet Antler extract on fatigue recovery after exercise. The investigators measured fatigue recovery parameters , including lactate, ammonia, inorganic phosphorus, creatine kinase and LDH, and monitored their blood pressure.

Interventions

DIETARY_SUPPLEMENTFermented Velvet Antler extract

Fermented Velvet Antler extract (1g/day)

DIETARY_SUPPLEMENTPlacebo

Placebo (1g/day)

Sponsors

Chonbuk National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females 19-60 years old * Hemoglobin concentration between 13 and 14 g/dL(men), 12 and 13 g/dL(women) * Able to give informed consent

Exclusion criteria

* Allergic or hypersensitive to any of the ingredients in the test products * History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery * Participation in any other clinical trials within past 2 months * Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study * Pregnant or lactating women etc.

Design outcomes

Primary

MeasureTime frameDescription
Changes in ammonia12 weeksAmmonia was measured in study visit 1(0 week) and visit 3(12 week).
Changes in creatine kinase12 weeksCreatine kinase was measured in study visit 1(0 week) and visit 3(12 week).
Changes in Lactage dehydrogenase(LDH)12 weeksLactage dehydrogenase(LDH) was measured in study visit 1(0 week) and visit 3(12 week).
Changes in lactate12 weeksLactate was measured in study visit 1(0 week) and visit 3(12 week).
Changes in inorganic phosphorus12 weeksInorganic phosphorus was measured in study visit 1(0 week) and visit 3(12 week).

Secondary

MeasureTime frameDescription
Changes in 36-Item Short-Form Health Survey(SF-36)12 weeks36-Item Short-Form Health Survey(SF-36) was measured in study visit 1(0 week) and visit 3(12 week).
Changes in Multidimensional Fatigue Scale(MFS)12 weeksMultidimensional Fatigue Scale(MFS) was measured in study visit 1(0 week) and visit 3(12 week).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026